Here, the authors show that targeting the ubiquitin peptidase USP47 overcomes TKI resistance and eliminates leukaemia stem/progenitor cells in primary and xenograft CML murine models. Here, USP47 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.